Pharmacology

Action Mechanism of Action Reference
INHIBITOR CD22 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lymphoma, Follicular 2 D008224 ClinicalTrials
Leukemia, Biphenotypic, Acute 2 D015456 ClinicalTrials
Lymphoma, Follicular 2 D008224 ClinicalTrials
Lymphoma, Large B-Cell, Diffuse 1 D016403 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2108666